What’s Under The Iceberg: GE Healthcare’s Deep Dive Look At Future Of Gene Therapy

Cell and gene therapy represent a transformative advance in drug delivery and outcomes, with implications equally as important to human progress as the digital revolution that began three decades ago.In Vivo speaks with a key player in this evolving field, GE Healthcare’s strategy manager for cell and gene therapy and board member of the Alliance for Regenerative Medicine, Phil Vanek, PhD.

Vanek_Phillip_1200x675
Phil Vanek, GE Healthcare's strategy manager for cell and gene therapy • Source: GE Healthcare

Technology around cell and gene therapy is progressing, with a simplified, cost-efficient improvement to today’s cumbersome viral vector delivery pathway likely in a matter of years.

GE Healthcare’s strategy manager for cell and gene therapy and board member of the Alliance for Regenerative Medicine, Phil...

More from C-Suite Speaks

More from Leadership